Related Experiment Video
Updated: Mar 23, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.3K
Tumour heterogeneity in the clinic
Philippe L Bedard1, Aaron R Hansen, Mark J Ratain
1Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, Ontario, Canada.
Nature
|September 20, 2013
Summary
Understanding cancer genetic variations between patients (interpatient heterogeneity) and within a tumor (intratumour heterogeneity) is key for targeted therapies. Sequencing helps track these changes and resistance during treatment.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Therapeutic advances in oncology rely on identifying tumour genotype variations.
- Interpatient heterogeneity predicts patient response to targeted treatments.
- Intratumour heterogeneity involves diverse cancer cell subpopulations within a single patient.
Purpose of the Study:
- To explore the role of genetic heterogeneity in cancer treatment.
- To highlight the application of sequencing technologies in characterizing tumour evolution.
- To address challenges posed by heterogeneity in clinical trial design.
Main Methods:
- Utilizing sequencing technologies to analyze tumour genetic profiles.
- Characterizing intratumour heterogeneity at diagnosis.
- Monitoring clonal dynamics and resistance during cancer therapy.
Main Results:
- Sequencing enables detailed characterization of intratumour heterogeneity.
- It allows for monitoring of clonal evolution under treatment pressure.
- Emergence of clinical resistance can be identified through genetic analysis.
Conclusions:
- Genetic heterogeneity, both interpatient and intratumour, significantly impacts cancer treatment strategies.
- Sequencing technologies are crucial tools for understanding and managing cancer heterogeneity.
- Addressing heterogeneity is vital for designing effective clinical trials and improving patient outcomes.
More Related Videos
Related Concept Videos
02:18Cancer
55.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
02:07Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
02:07Tumor Progression
3.5K
No description available
3.5K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
02:17The Tumor Microenvironment
3.0K
No description available
3.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K